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Background: The hybrid technique combines a mono or bilateral epicardial approach with a percutaneous
endocardial ablation in a single-step procedure. We present our early results with this technique employing a
monopolar radiofrequency source through a right thoracoscopy in patients with lone atrial fibrillation (LAF).
Methods: Between June 2009 and December 2010 nineteen consecutive patients (mean 60.8 ± 8.6 years,
84.2% male) underwent right unilateral minimally invasive hybrid procedure for LAF at our Institution. Ten patients
(52.6.6%) had long-standing persistent AF while four (21.1%) had persistent and five (26.3%) paroxysmal AF. All
patients were followed-up according the Heart Rhythm Society/European Heart Rhythm Association/European
Cardiac Arrhythmia Society (HRS/EHRA/ECA) and Society of Thoracic Surgeon (STS) guidelines.
Results: There were neither early nor late deaths. It was possible to complete all the procedures as planned
without any conversion to cardiopulmonary bypass. No patient died during the follow up. At one year, 7/19
(36.8%) patients were in sinus rhythm with no episode of AF and off antiarrhythmic drugs (AAD). Time-related
prevalence of postoperative AF peaked at 44.4% (41.3–47.4) at two weeks, was 30.4% (27.3–34.9) at three months,
fell to 14.2% (11.6–18.1) by 6 months and was 13.3% (11.0–17.4) at 12 months Among patients with long-standing
persistent (LSP) AF, 20% (2/10) were in Sinus rythm and off AAD. One-year success rates were 50% (2/4) in
persistent and 60% (3/5) in paroxysmal AF. At 12 months estimated prevalence of antyarrhythmic drugs and
Warfarin use were 26% (22.4–33.1) and 48% (37.2–53.2), respectively.
Conclusions: One year results combining the percutaneous endocardial with the right thoracoscopic epicardial
technique were, in our experience, not satisfactory, particularly in patients with LSP and persistent AF. Our findings
need to be confirmed by larger studies.
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Despite being more effective than percutaneous catheter
ablation (PCA) [1-3], the MAZE operation failed to
achieve widespread application as stand-alone procedure
because of its complexity and invasiveness. Indeed, the
Society for Thoracic Surgeons (STS) database [4]
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reproduction in any medium, provided the orin patients with lone atrial fibrillation (LAF). In addiition,
along with its suboptimal success rates, PCA showed a
non-negligible incidence of major complications [3].
New technologies have allowed the creation of trans-
mural lesions on a beating heart through alternative, less
invasive incisions [5]. Nonetheless, results reported in
the literature with these approaches are highly variable
[6-8].
More recently, a sequential one-step surgical/catheter-
based approach has been introduced showing satisfactory
results in patients with persistent LAF [9]. This so-called
hybrid procedure combines the advantages of PCA andLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Baseline Patient Characteristics (n = 19)
Age 61.2 ± 8.6
M/F 16/3 (84.2/15.8)






Type of preoperative AF
Paroxysmal 5 (26.3)
Persistent 4 (21.1)
Long-standing persistent 10 (52.6)
Prevalence of AF (68% CI)
Paroxysmal 20.0 (16.8–23.3)
Persistent 34.7 (31.2–38.9)
Long-standing persistent 63.6 (59.9–67.1)
EHRA Score 4 [3–4]







Electrical cardioversion 15 (78.9)
Previous Catheter Ablation
For AF 6 (31.5)
For Atrial Flutter 5 (26.3)
Preoperative Pacemaker 2 (10.5)
Anticoagulant status
Sodium Warfarin 16 (84.2)
Aspirin 5 (26.3)
LAVI (mL/m2) 47 ± 11
LAMAX (mL/m
2) 49 ± 20
LAMIN (mL/m
2) 30 ± 15
LAEF (%) 38 ± 12
LA A-P (cm) 5.0 ± 0.5
LA S-I (cm) 6.4 ± 0.5
Normal data were presented as mean ±1 Standard deviation (SD), non
parametric data as Median and [Interquartile Range] and discrete data as
percentage (%).
Abbreviations: M/F: Male/Female; BMI: Body mass index; AF: Atrial fibrillation;
CI: Confidence Interval; EHRA: European Hear Rhythm Association; LAVI:
(Biplane) Left Atrial Volume Index; LAMAX: Maximum Left Atrial Volume; LAMIN:
Minimum Left Atrial Volume; LAEF: Left Atrial emptying Fraction; LA A-P: Left
Atrial Antero-Posterior Diameter; LA S-I : Left Atrial Superior-Inferior diameter.
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it is expected to overcome the shortcomings of these
techniques [10].
As originally described, the hybrid technique employs
a bilateral thoracoscopic epicardial approach. We have
recently introduced a less-invasive hybrid single-sided
approach through a right thoracoscopy and, as far as we
know, there are no reports in the literature about the
effectiveness of this procedure.
Therefore, we present one-year results with minimally
invasive hybrid-right thoracoscopic approach employing




Ethical Committee approval was waived according to the
National law regulating observational retrospective stud-
ies (Dutch WMO law). However, all patients gave their
informed consent to access their data for scientific
purposes.
Between January 2008 and June 2010 nineteen con-
secutive patients underwent minimally invasive right-
thoracoscopic hybrid ablation of LAF employing a
monopolar RF source. LAF was defined as suggested by
American College of Cardiology/American Heart Asso-
ciation/European Society of Cardiology (ACC/AHA/
ESC) Guidelines [11] and updated ESC Guidelines were
followed to distinguish the type of AF and to score the
AF-related symptoms (European Heart Rhythm Associ-
ation [EHRA] score) [12]. Indication for minimally inva-
sive surgery was based on the Heart Rhythm Society/
European Heart Rhythm Association/European Cardiac
Arrhythmia Society (HRS/EHRA/ECA) Guidelines [13].
A trans-thoracic echocardiography (TTE) and a com-
puted tomography (CT) scan were carried out preopera-
tively (pulmonary vein anatomy, coronary arteries) and
potential candidates for the hybrid procedure underwent
a lung function test (spirometry). Exclusion criteria were:
1) Presence of left atrial or left appendage thrombus at
transesophageal echocardiography (TEE); 2) 00Giant00 left
atrium (diameter >6.5 cm); 3) Associated coronary ar-
tery disease; 4) Previous pulmonary or cardiac surgery.
Patient characteristics are shown in Table 1.
Follow-up and assessment of AF
All patients were followed-up according to Heart Rhythm
Society/European Heart Rhythm Association/European
Cardiac Arrhythmia Society (HRS/EHRA/ECA) [13]. Main
outcomes were also reported following the Society of
Thoracic Surgeon (STS) guidelines [14]. After hospital dis-
charge patients underwent 7-day Holter Monitoring (HM)
which was repeated at 3 months, 6 months and 1 year. All
patients reached 1-year follow up. Monitoring was carriedout with an external loop recorder (Del Mar Reynolds,
Spacelabs Healthcare, Issaquah, WA,USA) and analyzed
with Lifescreen Software (Del Mar Reynolds, Spacelabs
Healthcare, Issaquah, WA, USA). For analysis, three
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ter or atrial tachycardia lasting more than 30 sec. In
addition, all electrocardiograms (ECG) performed at the
discretion of referring physicians/cardiologists during the
first three months after surgery and between Holter exam-
inations were included when patients had at least two
records available for analysis. Each ECG and Holter was
treated as discrete data (presence/absence of atrial fibrilla-
tion) to calculate AF estimated prevalence [14]. A total of
222 postoperative Holter/ECG data were retrieved.Echocardiography
Echocardiography was performed preoperatively and at
3 month- and 12 month- follow-up appointments using a
commercially available echocardiographic system (Philips
iE33; Philips Medical Systems, Eindhoven, The Nether-
lands). All the parameters were analyzed “off-line” by an
experienced echocardiographer (F.L.) using the Xcelera
software (Philips Medical Systems Eindhoven, The
Netherlands).
In the parasternal long-axis views LA maximum
antero-posterior (A-P) diameter was measured. LA
superior-inferior (S-I) diameter was measured from the
mitral annular plane to the posterior wall of the LA in
the apical 4-chamber view. In the apical 4-chamber view,
LA maximum volume (LA max), at the end of LV sys-
tole, just before the opening of the mitral valve and LA
minimum volume (LA min) at the end of LV diastole,
just after the closure of the mitral valve, were measured
[15]. LA emptying fraction (LAEF) was calculated as fol-
lows: (LA max-LA min/LA max) × 100. LA maximum
volume was also measured by biplane area-length
method [16] and indexed to body surface area (LAVI).
LARR was defined as a reduction in LAVI ≥15% at late
follow up [17].Anticoagulation and antiarrhythmic therapy
Antiarrhythmic drugs (AAD) were given postoperatively
to all patients but, although we recommend discontinu-
ing antyarrhythmics 3 months after ablation if the
patients appears to be AF free, continued use is at the
discretion of referring cardiologists.
Electrical cardioversion was not attempted for patients
who remained in AF after the surgical procedure and
was reserved for patients who were still in AF after
6 months.
Warfarin was administered on postoperative day II
with INR target of 2.5 and stopped after 3 months if the
Holter recording showed a sinus rhythm (SR) or patient
had a low thromboembolic risk and a CHADS2 [cardiac
failure, hypertension, age, diabetes, stroke (doubled)]
score <2.Surgical technique
Theinterventionswereperformedundergeneralanesthesia
with a double-lumen endotracheal tube for selective lung
ventilation. The chest was entered in the second, fourth
and sixth interspaces using respectively a 5-12-12 mm
port. The technique was as previously reported [18].
High frequency stimulation (HFS) of the right vagal
nerve at the level of the mediastinum and at the four
major ganglionated plexi (GPS, [right superior GP, right
inferior GP, left superior GP and left inferior GP)] was
carried out and the vagal response on the atrio-
ventricular node was recorded (10 V, 1.5-ms pulse width
impulse at 1000 pulses per minute from a temporary ex-
ternal pacemaker [Oscor, Oscor INC., Palm Harbor, FL])
The isolation of pulmonary veins was performed with a
CobraW Adhere XL (Estech, Danville, Ca) temperature-
controlled, monopolar radiofrequency system. The abla-
tion catheter was pushed under the superior caval vein
(SCV) into the transverse sinus and placed behind the
left atrial appendage (LAA) encircling the four PVs to
create the box-lesion.
Before starting the ablation, the fat pad in the atrial
groove was bluntly dissected to provide a better place-
ment of the probe and enhance a higher penetration en-
ergy to destroy the GPs located inside this fat pad.
After creation of the box lesion the vagal response at
level of GPS was tested again. The endpoint for gangli-
onated plexi (GP) ablation was the elimination of a vagal
response to stimulation. In all patients this vagal re-
sponse could no longer be induced with HFS, except for
the right inferior GP which, being located outside the
box lesion was not to ablated in any patient.
A left femoral vein puncture was made and a HIS
bundle catheter (St Jude Medical, Inc, Minnetonka, MN,
USA) and a coronary sinus (CS) catheter (Medtronic,
Inc, Minneapolis, MN, USA) were placed under fluoro-
scopic guidance. Through the right femoral vein, a sin-
gle trans-septal puncture was made using TEE and
fluoroscopy and a long sheath 8 F (SL0, St. Jude Medical
Daig Division, Inc., Minnetonka, MN, USA) was
advanced into the LA. The patient was heparinzed to
keep the activated clotting time >300 seconds. During
rapid ventricular pacing from the HIS catheter, contrast
was injected through the long sheath in order to
visualize PVs and the LA. PVs were mapped with a suit-
ably sized circular mapping catheter (Lasso, Biosense
Webster, Inc, Diamond. Bar, CA, USA) placed at the
ostium of the PVs.
In all patients epicardial pacing and endocardial
recordings were utilized to demonstrate entrance and
exit block; entrance block was defined as failure to cap-
ture the PVs during pacing from the left atrium at 18 V
and 1.5-ms pulse width and the absence of pulmonary
vein potentials (PVPs) seen on the Lasso catheter. Exit
Table 2 Lesions set
Left atrium
Right PVs Isolation 19 (100)
Left PVs Isolation 19 (100)
Inferior line 19 (100)
Roof line 19 (100)
Isthmus lesion 3 (15.7)
Endocardial gaps closure 17 (88.4)
Right atrium
Cavo-tricuspid isthmus line 2 (10.5)
Ablation of autonomic Ganglia 19 (100)
Abbreviations. PVs: Pulmonary Veins.
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during the pacing from the PVs and by failure to capture
when pacing from each dipole of the Lasso catheter with
an output of 10 mA and 2.0 ms pulse width.
We identified the conduction gaps from the endocar-
dium which were closed endocardially with a 3.5 mm tip
catheter (ThermoCool, Biosense Webster, Inc., Diamond.
Bar, CA, USA) through the sheath in the LA. The precise
location of the linear lesions was visualized with the
CobraW Adhere XL (Estech, Danville, Ca) in situ and
using fluoroscopy. Gaps in linear lesions were defined as
low amplitude and fragmented or narrowly split double
atrial potentials.
In case of AF persistence, a left isthmus line was made
endocardially from the mitral annulus towards the CS
employing the ThermoCool catheter (ThermoCool,
Biosense Webster, Inc., Diamond. Bar, CA, USA) The
endpoint of ablation of the mitral isthmus was the bidir-
ectional block which was achieved when the following
criteria were met: 1) proximal-to-distal activation se-
quence along the CS catheter after pacing lateral to the
line in the LA appendage; 2) Late activation on the op-
posite side after pacing on the septal side of the line
through the CS; 3) widely separated local double poten-
tials along the whole length of the ablation line. Finally,
if the patient had a history of typical right atrial flutter
or this arrhythmia became apparent during the proced-
ure, we performed a cavo-tricuspid isthmus line (CTI)
endocardially. The endpoint was bidirectional block and
the presence of widely separated double potentials along
the whole length of the ablation line.
Statistical analysis
Normal values were expressed as mean± one standard
deviation (SD), non-normal values as median and inter-
quartile range (IQR) and categorical variables as percen-
tages. Student t, Wilcoxon and McNemar’s tests were
employed where appropriate.
We analyzed all the intermittent data available in
terms of time-related prevalence of AF [14] with a multi-
phase hazard decomposition method [19]. Prevalence of
AF was presented as percentage with asymmetric 68%
confidence obtained with the bootstrap percentile
method [20].
Analyses of prevalence of AF do not account for anti-
arrhythmic medications. Prevalence of antiarrhythmic
medication use was estimated by mixed modeling based
on medication use at each follow-up assessment. With
the same method we estimated the prevalence of War-
farin use at the time of each follow-up. Finally, the use
of electrical cardioversion was analyzed as a repeated
event and is presented as cumulative incidence [21].
Statistical analysis was performed using SPSS release
12.0 (SPSS, Chicago, IL, USA) and Curve ExpertProfessional release1.0.1 (D.G. Hyams, Chattanooga, TN,
USA). P values less than 0.05 were considered significant.Results
None of the patients showed entrance and/or exit block
after the epicardial ablation. Seventeen patients had at
least one PV not isolated, which needed an endocardial
touch-up (Table 2). After completing endocardial PV
isolation the entire population had a conduction
delay> 200 ms. in the posterior LA but no patient had
complete block.
Three patients (15.7%) underwent mitral isthmus line
and in all cases a complete block was achieved. A cavo-
tricuspid isthmus (CTI) line was carried out in two
patients (10.5%) with successful bidirectional block. All
surgical procedures were completed as planned without
any conversion to cardiopulmonary bypass. Median
operative time was 216 minutes (IQR 132–391). There
were neither early deaths nor complications during the
postoperative course. Median Intensive care unit (ICU)
stay was 6.9 hours [IQR 4.0–14.0] and median in-
hospital length of stay was 3.6 days [2.7–4.3].
No patient died during the follow up. There was a sig-
nificant improvement in median EHRA (European Hear
Rhythm Association) score at follow up (1[IQR 1–2],
p< 0.001 vs. baseline). At one year, 7/19 (36.8%) patients
were in sinus rhythm and off-AAD. Furthermore, 63.1%
(12/19), patients were free from AF, AFL or AT >30 s
but still under antiarrhythmic therapy (p= 0.1).
Time-related prevalence of postoperative AF was
44.4%(41.3–47.4) at two weeks, 30.4% (27.3–34.9) at
three months, 14.2% (11.6–18.1) at 6 months and 13.3%
(11.0–17.4) at 12 months (Figure 1A). Among patients
with long-standing persistent AF, 20% (2/10) were in SR
and off-AAD. One-year success rates were 50% (2/4) in
persistent and 60% (3/5) in paroxysmal AF. At 12 months
the estimated prevalence of antyarrhythmic drugs
(Figure 2A) was 26% (22.4–33.1). AAD-prevalences by
AF type were 38.1% (34.3–43.4) for long-standing
Figure 1 A. Time-related prevalence of Atrial Fibrillation after hybrid procedure. B. Time-related prevalence of Atrial Fibrillation by AF type.
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(9.9–17.8) for paroxysmal AF. Finally, time-related
prevalence of Warfarin (Figure 2B) at 1 year was 48.2%
(44.2–52.2). This figure was 52.5% (48.8–55.2) in long-
standing persistent, 35.3% (32.5–39.2) in persistent and
19.4% (16.3–23.3) in paroxysmal AF. The cumulative
incidence of electrical cardioversion was 0.05/patient.
LA function and remodeling
Table 3 shows postoperative echocardiographic data. At
3 month- follow-up biplane LAVI was reduced by 16%
(p= 0.05). It further decreased but not significantly at
1 year (p= 0.09). Based on the cut-off value (≥15% re-
duction in LAVI) LARR occurred in 47.3% (n = 9) of
patients. LAEF increased not significantly at 3 month-
(p= 0.6) and at 12-month- (p= 0.56) controls. Finally,
LA diameters decreased significantly at 3 months (LA
A-P, p= 0.02; LA S-I p= 0.03) whereas at one year there
was a further reduction which did not reach statistical
significance (LA A-P, p= 0.73; LA S-I p= 0.81).
Discussion
Minimally invasive surgical epicardial thoracoscopic
approaches have gained a growing popularity but data
regarding their efficacy are controversial [6-9,22-25].
The hybrid approach combines, in one step, athoracoscopic epicardial ablation with a PCA procedure
[9,26]. The surgeon, through a thoracoscopy, can isolate
the pulmonary veins and the posterior wall of the LA
whereas the endocardial “step” offers the possibility of
evaluating the endpoints of the ablation and it gives the
opportunity to add an endocardial “touch-up” in case
of incomplete epicardial PVs isolation. In addition, the
electrophysiologist (EP) can make lesions in regions
which cannot be reached epicardially. Moreover, this
technique may potentially decrease the complication
rate of both surgical and catheter ablation procedures.
Indeed, from the point of view of the surgeon, the risk
of post-operative arrhythmias is reduced since ablation
lines and lesion set can be controlled endocardially and
the risk of injury is lower, since the EP can make
lesions in areas which cannot be easily reached by the
surgeon.
On the other hand, from the EP point of view, there is
no risk of phrenic nerve and esophageal injury because
these structures can be protected by the surgeon and the
possibility of tamponade is low since the pericardium is
open. Furthermore, by reducing the total number of
endocardial ablations the risk of embolism is potentially
reduced [27].
We present our one-year results with minimally inva-
sive hybrid-right thoracoscopic approach employing a
Figure 2 A. Prevalence of class I/III anti-arrhythmic use after hybrid procedure. B. Prevalence of Warfarin use hybrid procedure.
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of LAF. Little information exists in the literature about
the hybrid technique [10,28] and, to the best of our
knowledge, no data exist on the right monolateral
monopolar hybrid approach.
The monolateral right-thoracoscopic approach could
theoretically reduce the rates of complications (bleeding,
pulmonary complications) and significantly shorten
patients' recovery time. Nonetheless, only monopolar
devices can be used through the right-thoracoscopy be-
cause of the lack of maneuverability of bipolar clamps
(which can hamper the orientation of the probe and
constrain the variety of achievable lesion sets when
employed from the right side) but many concerns have
been raised regarding the ability of monopolar devices to
create transmural lesion with bidirectional conduction
block on the beating heart [29].
This technique demonstrated, in our experience, a
high degree of safety with no major complications and
no major thromboembolic events detected during thefollow up period. Nonetheless, at one year only 36.8%(7/
19) patients were in SR and off-AAD. Among patients
with long-standing persistent AF, 20% (2/10) were in SR
and off-AAD. One-year success rates were 50% (2/4) in
persistent and 60% (3/5) in paroxysmal AF. Furthermore,
at 12 months, the estimated prevalence of antyarrhyth-
mic drugs was 26% (38.1% in LSP, 26.3%in persistent
and 14.9% in paroxysmal AF). The incidence of patients
without recurrent AF but with AAD was not signifi-
cantly lower compared with patients off-AAD (p= 0.1)
although this data must be interpreted taking into ac-
count the small number of patients in the study. There-
fore, this limitation does not allow us to draw any
conclusion about the role of AAD in the development of
AF recurrence following minimally invasive surgery.
However, the success rate, in this series, was lower
than published papers employing monopolar devices
[30] and it might be explained by the high number
of patients with long-standing persistent (LSP) and
persistent AF which represent 73.6% of our cohort.
Table 3 LA remodeling
LAVI (mL/m2)
3 months 45 ± 10




3 months 46 ± 15




3 months 27 ± 10
12 months 25 ± 8
p 0.86
LAEF (%)
3 months 41 ± 14
12 months 43 ± 14
p 0.56
LA A-P (cm)
3 months 3.9 ± 0.4*
12 months 3.7 ± 0.4
p 0.73
LA S-I (cm)
3 months 5.9 ± 0.6*
12 months 5.8 ± 0.6
p 0.81
Normal data were presented as mean ±1 Standard deviation (SD).
*Significance vs. Baseline. Abbreviations: LAVI: (Biplane) Left atrial volume
index; LAMax: Maximum left atrial volume; LAMin: minimum left atrial volume;
LAEF : Left atrial emptying fraction; LA A-P: Left atrial antero-posterior
diameter; LA S-I: Left atrial antero-posterior diameter.
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be advanced stages of the arrhythmia characterized by
significant changes in the atrial tissue and muscle
(substrate modification) that leads to chaotic electrical
activity. Thus, these patients might need more areas
in the heart ablated than in the monolateral approach
and they might benefit much more from procedures
which increase the likelihood that ablation lines are
transmural although this aspect may be addressed by
the EP who can complete any line by focused endo-
cardial applications. Indeed, in our experience, the in-
cidence of incomplete, non trans-mural gap lesions
was high, none of the patients showed entrance and/
or exit block after the epicardial ablation and,after
completing PV isolation endocardially, all patients had
a conduction delay> 200 ms. in the posterior LA but
no patient had complete block.
With this current knowledge we have stopped using
monopolar devices for the surgical treatment of AF, even
for patients where a monolateral approach may have apotential advantage i.e. in case of reduced pulmonary
function. In these patients we now perform a monolat-
eral approach from the right or left side, depending on
the wish to close the LAA, using bipolar devices10 and
isolating the opposed PVs endocardially with RF energy.
Finally, at latest follow up only 47.3% of patients
experienced LARR and there was no significant im-
provement in LAVI and LAEF. Due to the small number
of patients, we could not compare echocardiographic
data by AF type. However, again, the high percentage of
subjects with LSP or persistent AF reflects a greater ex-
tent of substrate modifications and atrial structural re-
modeling and this could explain the lack of LARR.
Indeed, all five patients with paroxysmal AF showed a
≥15% decrease in LAVI.
Limitations of the study
This study has some limitations which have to be
pointed out. The small patient population and the short
follow-up do not allow us to draw definite conclusions.
Larger series with long-term follow up are needed. Sec-
ond, only a small number of patients in this series
underwent right-sided and isthmus lesions and this
might have influenced the results. Third, our study did
not compare the hybrid right thoracoscopic approach
with the hybrid bilateral thoracoscopic approach to
evaluate the real impact of these different techniques on
outcome of LAF patients and to evaluate whether the
excision of the LAA, besides the management for pre-
vention of thromboembolic events, might have a con-
tribute to different rhythm outcome. Furthermore we
did not compare PCA with surgical thoracoscopic
approaches. However, all these aspects will be the sub-
jects of ongoing studies.
Fourth, while data regarding postoperative AF preva-
lence were obtained from a large number of observa-
tions and this allowed us to compare prevalence by AF
type, we could not evaluate LAVI, LAEF and LA dia-
meters in any subgroup of patients.
Finally, atrial function was studied employing only the
emptying fraction and neither pulsed-wave Doppler nor
Tissue Doppler Imaging (TDI) nor LA strain were
employed, which would have given more detailed infor-
mation about LA function after AF surgical ablation. All
these aspects deserve further investigations
Conclusions
One year results combining the percutaneous endocar-
dial with the right thoracoscopic epicardial technique
were, in our experience, not satisfactory, particularly in
patients with LSP and persistent AF. This approach might
still be considered a possible alternative to PCA in
selected patients with paroxysmal lone atrial fibrillation
and impaired pulmonary function referred to surgery
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Our findings need to be confirmed by larger studies.
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